When will remyelination treatment for MS be available? It's one of the most exciting questions in MS research right now — and the answer is cautiously optimistic.
Leading MS specialists believe remyelination therapies could be available within the next decade, possibly sooner. Some top researchers estimate we may be as Show Full Answer
When will remyelination treatment for MS be available? It's one of the most exciting questions in MS research right now — and the answer is cautiously optimistic.
Leading MS specialists believe remyelination therapies could be available within the next decade, possibly sooner. Some top researchers estimate we may be as little as five years away. To understand why this matters, here's a quick breakdown:
- MS damages myelin — the protective coating around your nerves
- Current disease-modifying therapies (DMTs) can reduce inflammation but cannot repair damage that has already occurred
- Remyelination therapy would actually recoat damaged nerves, potentially restoring or improving function
Researchers are currently studying several promising compounds, including:
- S1P receptor modulators (some already approved as DMTs)
- Clemastine fumarate (an antihistamine)
- Sex hormones, such as testosterone The goal of this research is to activate dormant cells in the brain called oligodendrocytes, which wrap around nerves and produce myelin. In people with MS, 5–8% of brain and spinal cord cells are these immature, inactive cells — just waiting to be switched on.
While some early clinical trials haven't succeeded yet, researchers remain determined and are planning new studies with fresh compounds. As one MS specialist put it, every setback makes the science a little smarter.
In the meantime, experts recommend staying proactive by taking an effective DMT, exercising regularly, maintaining healthy vitamin D levels, and eating well.
April 26
Join
Your Privacy Choices
